Our research is focused on optimising radiation therapies to improve patient outcomes, by feeding results into an accelerated clinical translation pipeline.
By sourcing expertise across discovery, translational and clinical research, and cultivating a modern research landscape aimed to spawn new cross-disciplinary interactions, we aim to unlock the full potential of radiotherapy for patient benefit.
The research hub will gather detailed information on three key areas:
• how tumours resist radiation and non-target toxicities
• ways to target tumours more precisely using new radio-sensitizers (DNA repair inhibitors)
• immunotherapy agents.
These will be supported by large-scale data collation, analysis and predictive computation.